Publications from 2021 to 2026
Filter Showing 10 of 5,409 papers
A novel molecularly imprinted graphene-graphite conductive paper electrode for selective electrochemical detection of hyaluronic acid in cosmetic formulations.
Constraining <mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si1.svg"> <mml:mrow> <mml:mi>f</mml:mi> <mml:mo>(</mml:mo> <mml:mi mathvariant="script">G</mml:mi> <mml:mo>)</mml:mo> </mml:mrow> </mml:math> gravity models using MCMC method
Impulsive stem cell transplantation to modulate psoriasis: Insights of complex cytokine network.
Capsule based regressor network for multivariate short term weather forecasting
DESIGN AND ANALYSIS OF A HIGH PERFORMANCE 915 MHz RF RECTIFIER WITH ENHANCED POWER CONVERSION EFFICIENCY FOR AMBIENT ENERGY HARVESTING IN WIRELESS SENSOR NETWORKS
DESIGN AND OPTIMIZATION OF A HIGH PERFORMANCE DUAL BAND RF RECTIFIER FOR AMBIENT ENERGY HARVESTING AT 1.80 GHz AND 5.2 GHz IN WIRELESS SENSOR AND IOT PLATFORMS
A DUAL BAND RF RECTIFIER FOR ENERGY HARVESTING AT 3.5 GHz AND 5.39 GHz IN 5G AND WIFI BASED AUTONOMOUS SENSING PLATFORMS
Cutting-edge nanotechnology in diabetes care: metamorphosing diagnostics and treatment strategies
Abstract Background Diabetes continues to pose a major challenge to the global health arena, while existing diagnostic and therapeutic toolkit are limited by invasive delivery methods, delayed glucose control, patient non-compliance, and long-term economic costs. These impediments have accelerated interest in nanotechnology-based methodologies to tackle diabetes. Main body of the abstract Recent advanced nano-systems have enabled the development of minimally invasive nanoscale glucose sensors and nanoparticle-derived imaging tools that facilitate continuous monitoring and early disease identification. In parallel, glucose-sensitive nanomaterials have been engineered to more closely replicate physiological insulin secretion. Nanocarrier platforms are also being explored for non-invasive insulin delivery, targeted gene silencing, and immunoprotective cell-based therapies aimed at preserving or restoring pancreatic β-cell function. Collectively, these approaches enhance sensitivity and targeting precision while advancing the prospect of closed-loop glycemic control. Despite this encouraging progression, a number of critical challenges persist. Concerns surrounding long-term biocompatibility and potential toxicity, inflammatory reactions to implantable systems, sensor instability, limitations in scalable manufacturing, and complex regulatory pathways continue to impede clinical translation. Moreover, a substantial proportion of nanotechnology-integrated solutions remain confined to preclinical research or early-stage clinical evaluation. Short conclusion While nanotechnology offers a compelling vision for the future of diabetes care, its translation into clinical practice demands thorough safety assessment, standardized frameworks, and evidence from large-scale clinical studies. Graphical abstract
Read moreGeometrical origin of growth of matter perturbations in Finslerian background
Global context and diversity of community archiving: memory, identity, and representation in community digital archives of the South Asian Diaspora
Copyright 2026 Cactus Communications. All rights reserved.
